Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Holler

Showing results (221-230 of 265) with videos related to

Pageof 27
Sort By:
Leukemia|June 18, 2004
Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantationC Schmid, M Schleuning, J Aschan, et al.
Bone Marrow Transplantation|February 16, 2000
Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantationE Holler, M G Roncarolo, R Hintermeier-Knabe, et al.
Leukemia|May 15, 2007
Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: a randomized multicenter trial by the EBMT Chronic Leukemia Working PartyS Knop, H Hebart, A Gratwohl, et al.
Bone Marrow Transplantation|January 1, 1989
Myeloablative conditioning for marrow transplantation in myelodysplastic syndromes and paroxysmal nocturnal haemoglobinuriaH J Kolb, E Holler, C Bender-Götze, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
Improved survival following HLA-incompatible bone marrow transplantation. Munich Cooperative Group of Bone Marrow TransplantationH J Kolb, C Bender-Götze, E Holler, et al.
Bone Marrow Transplantation|January 1, 1992
Cancer after bone marrow transplantation. IBMTR and EBMT/EULEP Study Group on Late EffectsH J Kolb, W Guenther, T Duell, et al.
Bone Marrow Transplantation|September 15, 2015
Identification and validation of biomarkers associated with acute and chronic graft versus host diseaseS S Ahmed, X N Wang, J Norden, et al.
Bioinformatics (Oxford, England)|September 17, 2016
Reference point insensitive molecular data analysisM Altenbuchinger, T Rehberg, H U Zacharias, et al.
Bone Marrow Transplantation|June 2, 2016
Identification and validation of biomarkers associated with acute and chronic graft versus host diseaseS S Ahmed, X N Wang, J Norden, et al.
Leukemia & Lymphoma|April 1, 1997
Inflammatory reactions induced by pretransplant conditioning--an alternative target for modulation of acute GvHD and complications following allogeneic bone marrow transplantation?E Holler, B Ertl, R Hintermeier-Knabe, et al.
Pageof 27

Showing results (221-230 of 265) with videos related to

Sort By:
Pageof 27
Leukemia|June 18, 2004
Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantationC Schmid, M Schleuning, J Aschan, et al.
Bone Marrow Transplantation|February 16, 2000
Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantationE Holler, M G Roncarolo, R Hintermeier-Knabe, et al.
Leukemia|May 15, 2007
Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: a randomized multicenter trial by the EBMT Chronic Leukemia Working PartyS Knop, H Hebart, A Gratwohl, et al.
Bone Marrow Transplantation|January 1, 1989
Myeloablative conditioning for marrow transplantation in myelodysplastic syndromes and paroxysmal nocturnal haemoglobinuriaH J Kolb, E Holler, C Bender-Götze, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
Improved survival following HLA-incompatible bone marrow transplantation. Munich Cooperative Group of Bone Marrow TransplantationH J Kolb, C Bender-Götze, E Holler, et al.
Bone Marrow Transplantation|January 1, 1992
Cancer after bone marrow transplantation. IBMTR and EBMT/EULEP Study Group on Late EffectsH J Kolb, W Guenther, T Duell, et al.
Bone Marrow Transplantation|September 15, 2015
Identification and validation of biomarkers associated with acute and chronic graft versus host diseaseS S Ahmed, X N Wang, J Norden, et al.
Bioinformatics (Oxford, England)|September 17, 2016
Reference point insensitive molecular data analysisM Altenbuchinger, T Rehberg, H U Zacharias, et al.
Bone Marrow Transplantation|June 2, 2016
Identification and validation of biomarkers associated with acute and chronic graft versus host diseaseS S Ahmed, X N Wang, J Norden, et al.
Leukemia & Lymphoma|April 1, 1997
Inflammatory reactions induced by pretransplant conditioning--an alternative target for modulation of acute GvHD and complications following allogeneic bone marrow transplantation?E Holler, B Ertl, R Hintermeier-Knabe, et al.
Pageof 27